| Literature DB >> 35089586 |
Junsoo Park1, Rackhyun Park2, Minsu Jang2, Yea-In Park2, Yeonjeong Park2.
Abstract
Coronavirus disease (COVID-19) can cause critical conditions that require efficient therapeutics. Several medicines are derived from plants, and researchers are seeking natural compounds to ameliorate the symptoms of COVID-19. Viral enzymes are popular targets of antiviral medicines; the genome of coronaviruses encodes several enzymes, including RNA-dependent RNA polymerase and viral proteases. Various screening systems have been developed to identify potential inhibitors. In this review, we describe the natural compounds that have been shown to exert inhibitory effects on coronavirus enzymes. Although computer-aided molecular structural studies have predicted several antiviral compound candidates, the current review focuses on experimentally proven natural compounds.Entities:
Keywords: COVID-19; SARS-CoV-2; coronavirus; natural compounds
Mesh:
Substances:
Year: 2022 PMID: 35089586 PMCID: PMC8795716 DOI: 10.1007/s12275-022-1499-z
Source DB: PubMed Journal: J Microbiol ISSN: 1225-8873 Impact factor: 2.902